HSBC Holdings’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $638K | Buy |
+57,214
| New | +$638K | ﹤0.01% | 1592 |
|
|
2024
Q3 | – | Sell |
-12,829
| Closed | -$108K | – | 2721 |
|
|
2024
Q2 | $108K | Buy |
+12,829
| New | +$108K | ﹤0.01% | 2351 |
|
|
2021
Q2 | – | Sell |
-10,412
| Closed | -$210K | – | 2578 |
|
|
2021
Q1 | $210K | Sell |
10,412
-1,718
| -14% | -$34.7K | ﹤0.01% | 2162 |
|
|
2020
Q4 | $212K | Hold |
12,130
| – | – | ﹤0.01% | 2344 |
|
|
2020
Q3 | $183K | Hold |
12,130
| – | – | ﹤0.01% | 2064 |
|
|
2020
Q2 | $254K | Sell |
12,130
-774
| -6% | -$16.2K | ﹤0.01% | 1842 |
|
|
2020
Q1 | $298K | Buy |
12,904
+3,759
| +41% | +$86.8K | ﹤0.01% | 1661 |
|
|
2019
Q4 | $240K | Buy |
+9,145
| New | +$240K | ﹤0.01% | 2173 |
|
|
2017
Q1 | – | Sell |
-6,914
| Closed | -$220K | – | 2054 |
|
|
2016
Q4 | $220K | Buy |
+6,914
| New | +$220K | ﹤0.01% | 2032 |
|